Search filters

Filters
Clear All

Phase

  • 2
  • 2
  • 11
  • 16
  • 13
  • 16

Found 16 Hemorrhage trials

A listing of Hemorrhage medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 OCEANIC-STROKE: Phase 3 study to investigate the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) compared with placebo in participants after an acute noncardioembolic ischemic stroke or high-risk TIA - 2023-28
18-100 years
All genders
Phase 3
The main purpose of this study is to learn whether asundexian works better than placebo at reducing ischemic strokes in participants who recently had a non-cardioembolic ischemic stroke or temporary stroke-like symptoms when given in addition to standard antiplatelet therapy.  The study treatment asundexian is a new type of anticoagulant …
99 years and younger
All genders
The primary objective of the study is to gather safety and effectiveness data in support of the Citadel Embolization Device for the treatment of intracranial aneurysms. Secondary objectives are to gain physician experience and expert clinical feedback on the design features of the Citadel Embolization Device to inform possible iterative …
 Phase 3  open label  single arm study to evaluate efficacy and safety of FIX gene transfer with PF-06838435 (rAAV Spark100-hFIX-Padua) in adult male participants with moderately severe to severe hemophilia B (FIX:C= or -2%) (BeneGene-2)
99 years and younger
All genders
Phase 3
The research study is being conducted to test the safety and effectiveness of the study drug which is a gene therapy based treatment. Researchers want to see if the drug works to prevent the bleeding episodes commonly experienced by patient with Hemophilia B and to advance science and medicine. Subjects …
99 years and younger
All genders
PURPOSE We aim to conduct a prospective observational study to test the central hypothesis that myocardial LM begins early after STEMI, as a response to myocardial hemorrhage and reperfusion injury, and determines future susceptibility to malignant arrhythmia. Study participants will be 175 (allowing for 25 dropouts) men and women 2 …
99 years and younger
All genders
The primary objective is to determine the safety and efficacy of GIE Medicals ProTractX3 TTS DCB for the treatment of recurrent benign bowel strictures. The ProTractX3 DCB is intended to treat benign strictures of the alimentary tract, combining mechanical dilation with localized delivery of the drug paclitaxel. The goal of …
99 years and younger
All genders
The primary objective of this study is to evaluate the safety and efficacy of the ProTractX3 DCB for the treatment of benign esophageal strictures. The ProTractX3 DCB is intended to treat benign strictures of the alimentary tract, combining mechanical dilation with localized delivery of the drug paclitaxel. The ProTractX3 DCB …
11 - 16 of 16